PROJECT 3- SYNAPTIC FUNCTION The proximal cause of cognitive impairment in Alzheimer?s disease (AD) is synaptic dysfunction and synaptic loss. As summarized in Projects 1 and 4, there is consistent evidence that amyloid-beta (a?) is associated with cognitive decline, that a? alone is not sufficient, and that rates of cognitive decline are considerably heterogeneous . Consequently, assessment of synaptic integrity is pivotal for linking the deleterious effects of AD and other age related pathology with resilience or susceptibility to cognitive decline. The goal of Project 3 is to explore and build upon our understanding and capacity to assess synaptic integrity within the AD spectrum and beyond through innovative multimodal PET and MRI imaging and quantitation.
In Aim 1, we will extend and build upon our prior work with resting state functional connectivity, focusing on relating longitudinal change in a composite measure of functional network connectivity to change in cognition, a?, tau, or modulating factors (Project 2).
In Aim 2, we will extend and build upon our multimodal functional imaging capabilities through inclusion and characterization of a proxy measure of relative blood flow derived from the wash-in of the PiB tracer ( PiB-R1). In conjunction with FDG-PET and resting state functional connectivity MRI (rs-fcMRI), we will evaluate whether PiB-R1 is a useful proxy for FDG, if change in PiB-R1 is an informative measure for cognition, molecular pathology, or modulating factors, and whether PiB-R1 can control for flow effects in other functional imaging modalities.
In Aim 3, we will go beyond the available arsenal of functional measures, with an exploratory investigation of a new synaptic imaging radioligand for TARP?8, the regulatory protein for AMPA receptors, that is highly expressed in hippocampus. This is a high risk, but potentially high reward, aim that is an important step towards a more direct assessment of synaptic integrity. Utilizing a subset of HABS participants, we will acquire TARP?8-PET imaging and assess relationships between TARP?8-PET and measures hypothesized to be related to synaptic dysfunction (age, cognition, hippocampal volume, FDG, and fMRI), as well as PET measures of Alzheimer?s disease molecular pathology. If successful, TARP?8-PET imaging will provide an opportunity to compare our functional imaging measures from Aims 1 and 2 to a more direct synaptic assessment and allow us to better characterize the extent and manner in which current functional imaging measures reflect synaptic integrity related to AMPA receptor signaling. By leveraging the rich longitudinal characterization of the HABS cohort, including data collected during the first two grant cycles, and the resources of the other projects and cores, Project 3 will focus on synaptic integrity as a means to bridge the gap between pathological markers with heterogeneous time-dependent influences and cognitive decline in order to provide a better understanding of brain aging and early AD.
| Chhatwal, Jasmeer P; Schultz, Aaron P; Johnson, Keith A et al. (2018) Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain 141:1486-1500 |
| Hanseeuw, Bernard J; Betensky, Rebecca A; Mormino, Elizabeth C et al. (2018) PET staging of amyloidosis using striatum. Alzheimers Dement 14:1281-1292 |
| Lee, Christopher M; Jacobs, Heidi I L; Marquié, Marta et al. (2018) 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. J Alzheimers Dis 62:1691-1702 |
| Buckley, Rachel F; Mormino, Elizabeth C; Amariglio, Rebecca E et al. (2018) Sex, amyloid, and APOE ?4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimers Dement 14:1193-1203 |
| Rieckmann, Anna; Johnson, Keith A; Sperling, Reisa A et al. (2018) Dedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging. Proc Natl Acad Sci U S A 115:10160-10165 |
| Makaretz, Sara J; Quimby, Megan; Collins, Jessica et al. (2018) Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry 89:1024-1031 |
| Lois, Cristina; Gonzalez, Ivan; Johnson, Keith A et al. (2018) PET imaging of tau protein targets: a methodology perspective. Brain Imaging Behav : |
| d'Oleire Uquillas, Federico; Jacobs, Heidi I L; Biddle, Kelsey D et al. (2018) Regional tau pathology and loneliness in cognitively normal older adults. Transl Psychiatry 8:282 |
| Donovan, Nancy J; Locascio, Joseph J; Marshall, Gad A et al. (2018) Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. Am J Psychiatry 175:530-537 |
| Properzi, Michael J; Buckley, Rachel F; Chhatwal, Jasmeer P et al. (2018) Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers. Neuroimage 186:446-454 |
Showing the most recent 10 out of 170 publications
